跳至主要内容
临床试验/NCT03162068
NCT03162068已完成不适用

Specificities of Cushing's Osteoporosis Compare to Postmenopausal Osteoporosis : pQCT Analysis in Comparison With a Group of Controls.

University Hospital, Clermont-Ferrand1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2017年4月4日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
50
试验地点
1
主要终点
Comparison of volumetric bone mineral density

研究概览

简要总结

Osteoporosis induced by glucocorticoids excess constitutes the main cause of secondary osteoporosis. Most of data available are provided from cohort studies of patients treated by corticosteroids, affecting among 1% of population. In contrast, very few data on osteoporosis are available in the Cushing syndrome (CS), a rare disease affecting 1 or 2 million of inhabitants, and characterized by an endogen glucocorticoid excess production. This affection is responsable of frequent fractures, occuring in 30-60% of patients (vertebral asymptomatic in 50% of case, hip, ribs). Fractures occurs often frequently above the threshold usually used for osteoporosis (T-score<-2.5), most often in the range of osteopenia. These data suggest that surface bone density isn't sufficient to characterize bone fragility, architectural factors are probably involved, and should be evaluated. The specificity of osteoporosis induced by endogen glucocorticoids excess in comparison with osteoporosis induced by estrogenic deficiency in post-menopausal women is poorly known, especially in endogen glucocorticoid excess.

A recent microarchitecture studies showed alterations of cortical compartment in patients with Cushing's syndrome, confirming by our preliminary preclinical data from a transgenic murin model of Cushing's syndrome.

In these ten last years, new radiologic tools have been developped, and are able to evaluate bone architecture. The peripheral Quantitative Computed analyses the bone architecture with distinction between cortical and trabecular compartment.

Therefore, we aim to determine the specificity of osteoporosis induced by glucocorticoids excess in comparison to post menopausal osteoporosis thanks to pQCT analysis.

详细描述

This study are divided in two parts :

  • Cross sectional cohort with both comparison between : Cushing syndrome versus control and cushing syndrome versus post-menopausal women

Outcomes :

Primary outcomes : Analysis thanks to pQCT will be carried out in order to compare radius and tibia bone mineral volume (total, trabecular and cortical)

Secondary outcomes :

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy Volunteers
  • Men and women> 18 years
  • No known chronic treatment or pathology
  • Absence of tobacco or alcohol
  • Normal bone mineral density for age (Z-score> -2 and T-score> -2.5) and markers of bone remodeling in normal values for age and menopausal status (osteocalcin, CTX)
  • Free 24-hour urinary cortisol (CLU / 24 h) normal Cushing matching by menopausal status, age group, BMI, sex
  • Postmenopausal women
  • Menopause confirmed by hormonal assays
  • Amenorrhea for more than one year
  • Free 24-hour urinary cortisol (CLU / 24 h) normal
  • Osteoporosis confirmed at DXA (T score ≤ -2.5 DS) Post menopausal women matching according to BMI, T-DXA score (T score ≤ -2.5 DS)
  • Cushing's syndrome
  • Endogenous hypercorticism, whatever the cause (dependent or independent ACTH)
  • Active or controlled for less than 5 years

排除标准

  • Diseases with bone resonance:
  • Disease that can affect phosphocalcium metabolism or promote bone loss: endocrine diseases (hyperparathyroidism, hyperthyroidism); Osteomalacia, malabsorptive intestinal or inflammatory or chronic liver diseases, chronic inflammatory rheumatism.
  • Heavy comorbidities: heart failure or chronic respiratory insufficiency, known severe renal insufficiency.
  • Treatments:
  • Anti-osteoporotic treatments (bisphosphonates, raloxifene, denosumab)
  • Teriparatide; Lithium, thiazide diuretic, treatment with levothyrox suppressive dose, hormone replacement therapy of menopause, anticonvulsants, corticotherapy in progress or in the previous 5 years, anti-aromatases, anti-androgenic
  • Minors, pregnant women
  • Patients unable to express their will (sub-tutelage, curators, dementia).
  • Lack of social security
  • Lack of follow-up
  • Excessive consumption of alcohol

结局指标

主要结局

Comparison of volumetric bone mineral density

时间窗: at day 1

thanks to pQCT with evaluation of total, trabecular and cortical compartment, between patients affecting by cushing'syndrome and post-menopausal women

次要结局

  • Assessment of trabecular and cortical compartment(at day 1)
  • Assessment of strength bone of radius and tibia of the non-dominant limb(at day 1)
  • Comparison of muscle area and surface, adipose tissue(at day 1)

研究者

发起方
University Hospital, Clermont-Ferrand
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验